|
1
|
Comorbidity and survival disparities among black and white patients with breast cancer.
|
JAMA
|
2005
|
3.27
|
|
2
|
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
|
Cancer Discov
|
2011
|
2.77
|
|
3
|
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
|
Cancer Discov
|
2011
|
1.77
|
|
4
|
Routine surveillance care after cancer treatment with curative intent.
|
Med Care
|
2005
|
1.45
|
|
5
|
An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.
|
Curr Biol
|
2009
|
1.30
|
|
6
|
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples.
|
Clin Cancer Res
|
2008
|
1.25
|
|
7
|
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.
|
Cell Metab
|
2013
|
1.23
|
|
8
|
A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.
|
Cancer Res
|
2010
|
1.20
|
|
9
|
Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress.
|
J Exp Med
|
2012
|
1.16
|
|
10
|
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.
|
Proc Natl Acad Sci U S A
|
2012
|
1.15
|
|
11
|
De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.
|
Cancer Discov
|
2013
|
1.07
|
|
12
|
Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
|
Cancer
|
2006
|
0.93
|
|
13
|
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas.
|
Clin Cancer Res
|
2013
|
0.91
|
|
14
|
Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.
|
Cancer Discov
|
2012
|
0.88
|
|
15
|
Blastic plasmacytoid dendritic cell neoplasm.
|
Am J Hematol
|
2011
|
0.87
|
|
16
|
Fast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging system.
|
J Nucl Med
|
2013
|
0.83
|
|
17
|
Evaluation of the Genisys4, a bench-top preclinical PET scanner.
|
J Nucl Med
|
2013
|
0.81
|
|
18
|
GLP-1R activation for the treatment of stroke: updating and future perspectives.
|
Rev Endocr Metab Disord
|
2014
|
0.77
|
|
19
|
[Glycemic index--trend or therapy?].
|
Lakartidningen
|
2007
|
0.75
|
|
20
|
Evaluating post-treatment screening in women with breast cancer.
|
Cancer Pract
|
2002
|
0.75
|